| Mirha Avdagic, MD | |
|
3619 Richardson Square Dr, Ste 170, Arnold, MO 63010-6022 | |
| (636) 717-6776 | |
| (314) 525-4055 |
| Full Name | Mirha Avdagic |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 37 Years |
| Location | 3619 Richardson Square Dr, Arnold, Missouri |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154625887 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | BP10033051 (Texas) | Secondary |
| 207Q00000X | Family Medicine | 2011025918 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy Hospital South | Saint louis, MO | Hospital |
| Mercy Hospital St Louis | Saint louis, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mercy Clinic East Communities | 7214827922 | 491 |
News Archive
The U.S. Food and Drug Administration today approved a new indication for Tasigna (nilotinib) for the treatment of a rare blood cancer when it is first diagnosed. The cancer, called Philadelphia chromosome positive chronic phase chronic myeloid leukemia (Ph+ CP-CML), is a slowly progressing blood and bone marrow disease linked to a genetic abnormality.
While a pint-sized snorer may seem adorable tucked up in bed, studies shows that children with sleep disordered breathing are likely to show aggressive and hyperactive behaviours during the day.
Ebola, the deadly viral infection, is spreading in Congo and the World Health Organization (WHO) has announced it as an international health emergency. Speaking in front of reporters, WHO Director-General Tedros Adhanom Ghebreyesus gave updates on the situation in the Central African country.
Merrimack Pharmaceuticals was awarded $2.44 million to support research on 10 of its cancer programs through the Qualifying Therapeutic Discovery Project, a grant program created as part of the Patient Protection and Affordable Care Act of 2010 to advance research in areas of unmet medical need.
Researchers and physicians in the field could soon run on-the-spot tests for environmental toxins, medical diagnostics, food safety and more with their smartphones.
› Verified 1 days ago
| Entity Name | Mercy Hospitals East Communities |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427098169 PECOS PAC ID: 1658276811 Enrollment ID: O20031209000789 |
News Archive
The U.S. Food and Drug Administration today approved a new indication for Tasigna (nilotinib) for the treatment of a rare blood cancer when it is first diagnosed. The cancer, called Philadelphia chromosome positive chronic phase chronic myeloid leukemia (Ph+ CP-CML), is a slowly progressing blood and bone marrow disease linked to a genetic abnormality.
While a pint-sized snorer may seem adorable tucked up in bed, studies shows that children with sleep disordered breathing are likely to show aggressive and hyperactive behaviours during the day.
Ebola, the deadly viral infection, is spreading in Congo and the World Health Organization (WHO) has announced it as an international health emergency. Speaking in front of reporters, WHO Director-General Tedros Adhanom Ghebreyesus gave updates on the situation in the Central African country.
Merrimack Pharmaceuticals was awarded $2.44 million to support research on 10 of its cancer programs through the Qualifying Therapeutic Discovery Project, a grant program created as part of the Patient Protection and Affordable Care Act of 2010 to advance research in areas of unmet medical need.
Researchers and physicians in the field could soon run on-the-spot tests for environmental toxins, medical diagnostics, food safety and more with their smartphones.
› Verified 1 days ago
| Entity Name | Mercy Clinic East Communities |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851335228 PECOS PAC ID: 7214827922 Enrollment ID: O20070521000006 |
News Archive
The U.S. Food and Drug Administration today approved a new indication for Tasigna (nilotinib) for the treatment of a rare blood cancer when it is first diagnosed. The cancer, called Philadelphia chromosome positive chronic phase chronic myeloid leukemia (Ph+ CP-CML), is a slowly progressing blood and bone marrow disease linked to a genetic abnormality.
While a pint-sized snorer may seem adorable tucked up in bed, studies shows that children with sleep disordered breathing are likely to show aggressive and hyperactive behaviours during the day.
Ebola, the deadly viral infection, is spreading in Congo and the World Health Organization (WHO) has announced it as an international health emergency. Speaking in front of reporters, WHO Director-General Tedros Adhanom Ghebreyesus gave updates on the situation in the Central African country.
Merrimack Pharmaceuticals was awarded $2.44 million to support research on 10 of its cancer programs through the Qualifying Therapeutic Discovery Project, a grant program created as part of the Patient Protection and Affordable Care Act of 2010 to advance research in areas of unmet medical need.
Researchers and physicians in the field could soon run on-the-spot tests for environmental toxins, medical diagnostics, food safety and more with their smartphones.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mirha Avdagic, MD 3619 Richardson Square Dr, Ste 170, Arnold, MO 63010-6022 Ph: (636) 717-6776 | Mirha Avdagic, MD 3619 Richardson Square Dr, Ste 170, Arnold, MO 63010-6022 Ph: (636) 717-6776 |
News Archive
The U.S. Food and Drug Administration today approved a new indication for Tasigna (nilotinib) for the treatment of a rare blood cancer when it is first diagnosed. The cancer, called Philadelphia chromosome positive chronic phase chronic myeloid leukemia (Ph+ CP-CML), is a slowly progressing blood and bone marrow disease linked to a genetic abnormality.
While a pint-sized snorer may seem adorable tucked up in bed, studies shows that children with sleep disordered breathing are likely to show aggressive and hyperactive behaviours during the day.
Ebola, the deadly viral infection, is spreading in Congo and the World Health Organization (WHO) has announced it as an international health emergency. Speaking in front of reporters, WHO Director-General Tedros Adhanom Ghebreyesus gave updates on the situation in the Central African country.
Merrimack Pharmaceuticals was awarded $2.44 million to support research on 10 of its cancer programs through the Qualifying Therapeutic Discovery Project, a grant program created as part of the Patient Protection and Affordable Care Act of 2010 to advance research in areas of unmet medical need.
Researchers and physicians in the field could soon run on-the-spot tests for environmental toxins, medical diagnostics, food safety and more with their smartphones.
› Verified 1 days ago
Molly Meghann Henson, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1296 Jeffco Blvd, Arnold, MO 63010 Phone: 636-321-8600 | |
Dr. Christopher S Abercrombie, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1237 Water Tower Pl, Arnold, MO 63010 Phone: 636-282-9899 | |
Dr. Sudha Pai, M.D Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3619 Richardson Square Dr, Arnold, MO 63010 Phone: 636-717-6700 Fax: 636-464-6755 | |
Dr. Fariha Qayum, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3619 Richardson Square Dr, Arnold, MO 63010 Phone: 636-717-6700 Fax: 636-464-6755 | |
Patricia Weilert, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3619 Richardson Square Dr, Arnold, MO 63010 Phone: 636-717-6700 Fax: 636-464-6755 | |
Dr. Mary Beth Chitwood, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3619 Richardson Square Dr, Suite 170, Arnold, MO 63010 Phone: 636-717-6776 Fax: 314-525-4055 |